^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BAT4306F

    i
    Other names: BAT4306F, BAT 4306F
    Associations

    News

    Trials
    Company:
    Bio-Thera Solutions
    Drug class:
    CD20 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients (clinicaltrials.gov)
    P1, N=16, Completed, Bio-Thera Solutions | Unknown status --> Completed | N=65 --> 16
    Trial completion • Enrollment change
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 positive
    |
    BAT4306F